RALOXIFENE vs TOREMIFENE CITRATE

Compare RALOXIFENE (Raloxifene Hydrochloride) and TOREMIFENE CITRATE (Fareston) — clinical data, side effects, and patient experiences.

RALOXIFENE

Raloxifene Hydrochloride, Evista · SERM

How it works

12.1 Mechanism of Action Raloxifene is an estrogen agonist/antagonist, commonly referred to as a selective estrogen receptor modulator (SERM). The biological actions of raloxifene ...

Approved for

1 INDICATIONS AND USAGE Raloxifene hydrochloride tablet

reduction of the risk of recurrence of breast cancer

or reduction of risk of noninvasive breast cancer. ( 1.3 ) 1.1 Treatment and Prevention of Osteoporosis in Postmenopausal Women Raloxifene hydrochloride tablets

USP are indicated for the treatment and prevention of osteoporosis in postmenopausal women [see Clinical Studies (14.1

OralTablet

TOREMIFENE CITRATE

Fareston · SERM

How it works

12.1 Mechanism of Action Toremifene is a nonsteroidal triphenylethylene derivative. Toremifene binds to estrogen receptors and may exert estrogenic, antiestrogenic, or both activit...

Approved for

See full prescribing information

OralTablet

Quick Comparison

RALOXIFENETOREMIFENE CITRATE

Drug Class

SERM

Route

Oral

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

RALOXIFENE

Nausea

1-10%

Falls

1-10%

Drug Not Working

1-10%

Limb Pain

1-10%

Joint Pain

1-10%

Dizziness

1-10%

Fatigue

1-10%

Headache

1-10%

TOREMIFENE CITRATE

Fatigue

1-10%

Peripheral Edema

1-10%

Fever

1-10%

General Unwellness

1-10%

FDA Warnings

RALOXIFENE

5 WARNINGS AND PRECAUTIONS Venous Thromboembolism: Increased risk of deep vein thrombosis, pulmonary embolism, and retinal vein thrombosis
1 ) Death Due to Stroke: Increased risk of death due to stroke occurred in a trial in postmenopausal women with documented coronary heart disease or at increased risk for major coronary events
No increased risk of stroke was seen in this trial
Consider risk-benefit balance in women at risk for stroke

TOREMIFENE CITRATE

5 WARNINGS AND PRECAUTIONS Prolongation of the QT Interval ( 5
3 ) Risk of Uterine Malignancy ( 5
Prolongation of the QT interval can result in a type of ventricular tachycardia called Torsade de pointes, which may result in syncope, seizure, and/or death
In patients at increased risk, electrocardiograms (ECGs) should be obtained at baseline and as clinically indicated [see Drug Interactions (7

Clinical Trial Data

No head-to-head clinical studies found for RALOXIFENE vs TOREMIFENE CITRATE.

RALOXIFENE vs TOREMIFENE CITRATE: What You Should Know

Key Differences

Both RALOXIFENE and TOREMIFENE CITRATE belong to the SERM class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

RALOXIFENE carries 4 FDA warnings. TOREMIFENE CITRATE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

RALOXIFENE HYDROCHLORIDE vs TOREMIFENE CITRATE→RALOXIFENE vs RALOXIFENE HYDROCHLORIDE→TAMOXIFEN CITRATE vs TOREMIFENE CITRATE→RALOXIFENE vs TAMOXIFEN CITRATE→RALOXIFENE vs TERIPARATIDE→RALOXIFENE vs ZOLEDRONIC ACID→

Loading comparison data...

RALOXIFENE vs TOREMIFENE CITRATE

Compare RALOXIFENE (Raloxifene Hydrochloride) and TOREMIFENE CITRATE (Fareston) — clinical data, side effects, and patient experiences.

RALOXIFENE

Raloxifene Hydrochloride, Evista · SERM

How it works

12.1 Mechanism of Action Raloxifene is an estrogen agonist/antagonist, commonly referred to as a selective estrogen receptor modulator (SERM). The biological actions of raloxifene ...

Approved for

1 INDICATIONS AND USAGE Raloxifene hydrochloride tablet

reduction of the risk of recurrence of breast cancer

or reduction of risk of noninvasive breast cancer. ( 1.3 ) 1.1 Treatment and Prevention of Osteoporosis in Postmenopausal Women Raloxifene hydrochloride tablets

USP are indicated for the treatment and prevention of osteoporosis in postmenopausal women [see Clinical Studies (14.1

OralTablet

TOREMIFENE CITRATE

Fareston · SERM

How it works

12.1 Mechanism of Action Toremifene is a nonsteroidal triphenylethylene derivative. Toremifene binds to estrogen receptors and may exert estrogenic, antiestrogenic, or both activit...

Approved for

See full prescribing information

OralTablet

Quick Comparison

RALOXIFENETOREMIFENE CITRATE

Drug Class

SERM

Route

Oral

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

RALOXIFENE

Nausea

1-10%

Falls

1-10%

Drug Not Working

1-10%

Limb Pain

1-10%

Joint Pain

1-10%

Dizziness

1-10%

Fatigue

1-10%

Headache

1-10%

TOREMIFENE CITRATE

Fatigue

1-10%

Peripheral Edema

1-10%

Fever

1-10%

General Unwellness

1-10%

FDA Warnings

RALOXIFENE

5 WARNINGS AND PRECAUTIONS Venous Thromboembolism: Increased risk of deep vein thrombosis, pulmonary embolism, and retinal vein thrombosis
1 ) Death Due to Stroke: Increased risk of death due to stroke occurred in a trial in postmenopausal women with documented coronary heart disease or at increased risk for major coronary events
No increased risk of stroke was seen in this trial
Consider risk-benefit balance in women at risk for stroke

TOREMIFENE CITRATE

5 WARNINGS AND PRECAUTIONS Prolongation of the QT Interval ( 5
3 ) Risk of Uterine Malignancy ( 5
Prolongation of the QT interval can result in a type of ventricular tachycardia called Torsade de pointes, which may result in syncope, seizure, and/or death
In patients at increased risk, electrocardiograms (ECGs) should be obtained at baseline and as clinically indicated [see Drug Interactions (7

Clinical Trial Data

No head-to-head clinical studies found for RALOXIFENE vs TOREMIFENE CITRATE.

RALOXIFENE vs TOREMIFENE CITRATE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.